The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) announced on July 9, 2025, that it will no longer conduct environmental analyses under the National Environmental Policy Act (NEPA) when...more
7/28/2025
/ APHIS ,
Biotechnology ,
CEQ ,
Deregulation ,
Environmental Assessments ,
Environmental Policies ,
Genetically Engineered Seed ,
Government Agencies ,
Judicial Review ,
NEPA ,
Regulatory Agencies ,
Regulatory Reform ,
Risk Assessment ,
Statutory Authority ,
Statutory Interpretation ,
USDA
USDA Animal and Plant Health Inspection Service (APHIS) announced on January 23, 2025, that it is reinstating its legacy notification procedure as of February 7, 2025, providing a streamlined alternative to permits for...more
2/18/2025
/ Agricultural Sector ,
APHIS ,
Biotechnology ,
Compliance ,
CRISPR ,
Final Rules ,
Genetically Engineered Seed ,
Innovation ,
Life Sciences ,
Regulatory Reform ,
Regulatory Requirements ,
USDA
In a decision that raises significant questions about the future oversight of genetically engineered (GE) plants in the United States, the U.S. District Court for the Northern District of California on Monday, December 2,...more
12/9/2024
/ Agricultural Sector ,
APHIS ,
Appeals ,
Bioengineering ,
Crops ,
DNA ,
Federal Rules of Civil Procedure ,
Genetically Engineered Seed ,
Modification ,
Plant Based Products ,
Regulatory Agenda ,
Regulatory Oversight ,
Regulatory Standards ,
USDA
After much anticipation, the EU Commission’s proposal for a regulation on plants developed using New Genomic Techniques (NGTs) is now under consideration. For an overview of the EU proposal, please see MoFo’s recent post....more
7/3/2023
/ Agricultural Marketing Act ,
APHIS ,
Biotechnology ,
EU ,
Food and Drug Administration (FDA) ,
Genetically Engineered Seed ,
Life Sciences ,
Medical Foods ,
Pharmaceutical Industry ,
Plant Based Products ,
USDA
On September 7, 2022, the United States Department of Agriculture’s Animal and Plant Health Inspection Service (USDA-APHIS) announced the completion of the first Regulatory Status Review (RSR) of a genetically engineered...more